Clinical Trial Update: An Optional Two Year Follow Up Study to Study CP005A

View source ↗

Summary

Two-year follow-up study to CP005A by Circassia has completed, investigating cat allergy and rhinoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy
• Rhinoconjunctivitis

Drugs mentioned

• CP005A

Snippet

Sponsor: Circassia Limited | Conditions: Cat Allergy, Rhinoconjunctivitis | Status: COMPLETED